Jianhui Tian

1.5k total citations
70 papers, 1.2k citations indexed

About

Jianhui Tian is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Jianhui Tian has authored 70 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 28 papers in Molecular Biology and 20 papers in Cancer Research. Recurrent topics in Jianhui Tian's work include Cancer Cells and Metastasis (12 papers), Immune cells in cancer (9 papers) and Lung Cancer Treatments and Mutations (8 papers). Jianhui Tian is often cited by papers focused on Cancer Cells and Metastasis (12 papers), Immune cells in cancer (9 papers) and Lung Cancer Treatments and Mutations (8 papers). Jianhui Tian collaborates with scholars based in China, United States and South Korea. Jianhui Tian's co-authors include Zujun Que, Hegen Li, Jianchun Wu, Yingbin Luo, Zhihong Fang, Jianwen Liu, Wenjing Teng, Lingshuang Liu, Bin Luo and Yuanhong Zheng and has published in prestigious journals such as Analytical Chemistry, Current Biology and Science Advances.

In The Last Decade

Jianhui Tian

64 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianhui Tian China 21 612 350 344 231 189 70 1.2k
Jihong Feng China 20 696 1.1× 346 1.0× 333 1.0× 207 0.9× 140 0.7× 49 1.2k
Yubo Tang China 20 1.0k 1.7× 314 0.9× 606 1.8× 174 0.8× 145 0.8× 49 1.6k
Zahra Asadzadeh Iran 23 668 1.1× 573 1.6× 320 0.9× 140 0.6× 458 2.4× 45 1.7k
Elizabeth Ortíz-Sánchez Mexico 19 596 1.0× 471 1.3× 253 0.7× 133 0.6× 173 0.9× 41 1.2k
Nan Yao China 18 854 1.4× 266 0.8× 306 0.9× 106 0.5× 129 0.7× 31 1.3k
Qinghua Yao China 21 653 1.1× 314 0.9× 220 0.6× 118 0.5× 162 0.9× 62 1.2k
Peng Gong China 21 467 0.8× 399 1.1× 216 0.6× 134 0.6× 133 0.7× 68 1.2k
Arash Soltani Iran 18 539 0.9× 451 1.3× 227 0.7× 155 0.7× 332 1.8× 32 1.3k
Wen Jiang China 21 612 1.0× 233 0.7× 228 0.7× 136 0.6× 249 1.3× 60 1.2k

Countries citing papers authored by Jianhui Tian

Since Specialization
Citations

This map shows the geographic impact of Jianhui Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianhui Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianhui Tian more than expected).

Fields of papers citing papers by Jianhui Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianhui Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianhui Tian. The network helps show where Jianhui Tian may publish in the future.

Co-authorship network of co-authors of Jianhui Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Jianhui Tian. A scholar is included among the top collaborators of Jianhui Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianhui Tian. Jianhui Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Que, Zujun, Dan Qi, Yun Yang, et al.. (2025). Regulating chemoresistance and cancer stemness: the CDH17-YAP pathway in distinct cellular states of lung cancer CTC clusters. Cellular & Molecular Biology Letters. 30(1). 23–23. 5 indexed citations
2.
Xu, Lili, Jianchun Wu, Jianhui Tian, et al.. (2025). Machine Learning Unveils Sphingolipid Metabolism's Role in Tumour Microenvironment and Immunotherapy in Lung Cancer. Journal of Cellular and Molecular Medicine. 29(7). e70435–e70435. 2 indexed citations
3.
Zhang, Long, Yanhong Wang, Zujun Que, et al.. (2025). TSZAF monomer combination downregulates the Wnt/β-catenin signaling pathway and inhibits neutrophil recruitment to prevent lung cancer metastasis. Chinese Journal of Natural Medicines. 23(9). 1069–1079. 1 indexed citations
4.
Wang, Mengfei, Meng Xu, Ziqi Chen, et al.. (2024). Paris saponin VII reverses resistance to PARP inhibitors by regulating ovarian cancer tumor angiogenesis and glycolysis through the RORα/ECM1/VEGFR2 signaling axis. International Journal of Biological Sciences. 20(7). 2454–2475. 6 indexed citations
5.
Zhang, Zhipeng, Yao Wang, Xiaoyu Yang, et al.. (2024). Maimendong decoction inhibits lung cancer metastasis by increasing the proportion and killing activity of NK cells. Journal of Ethnopharmacology. 338(Pt 3). 119127–119127. 2 indexed citations
6.
Yang, Yun, Li Zhu, Yu Pan, et al.. (2023). Jinfukang inhibits clustering and invasion of circulating lung tumor cells by regulating the EGFR signaling pathway. Acta Biochimica et Biophysica Sinica. 55(11). 1851–1854. 1 indexed citations
7.
Luo, Bin, Zujun Que, Dan Qi, et al.. (2023). Identification of exosome protein panels as predictive biomarkers for non-small cell lung cancer. Biological Procedures Online. 25(1). 29–29. 16 indexed citations
8.
Que, Zujun & Jianhui Tian. (2022). New strategy for antimetastatic treatment of lung cancer: a hypothesis based on circulating tumour cells. Cancer Cell International. 22(1). 356–356. 4 indexed citations
9.
Xu, Lili, Yingbin Luo, Jianhui Tian, et al.. (2022). A validated nomogram integrating baseline peripheral T-lymphocyte subsets and NK cells for predicting survival in stage I–IIIA non-small cell lung cancer after resection. Annals of Translational Medicine. 10(5). 250–250. 4 indexed citations
10.
Luo, Yingbin, Jianhui Tian, Zhihong Fang, et al.. (2022). Sanguinarine Regulates Tumor-Associated Macrophages to Prevent Lung Cancer Angiogenesis Through the WNT/β-Catenin Pathway. Frontiers in Oncology. 12. 732860–732860. 23 indexed citations
11.
Wang, Yuli, Yingbin Luo, Zhihong Fang, et al.. (2021). Yu-Ping-Feng Formula Exerts Antilung Cancer Effects by Remodeling the Tumor Microenvironment through Regulating Myeloid-Derived Suppressor Cells. Evidence-based Complementary and Alternative Medicine. 2021. 1–16. 6 indexed citations
12.
Wang, Yuli, Jianchun Wu, Lili Xu, et al.. (2021). Chinese Herbal Prescription Fu‐Zheng‐Qu‐Xie Prevents Recurrence and Metastasis of Postoperative Early‐Stage Lung Adenocarcinoma: A Prospective Cohort Study Followed with Potential Mechanism Exploration. Oxidative Medicine and Cellular Longevity. 2021(1). 6673828–6673828. 7 indexed citations
13.
Wang, Yuli, Ping Liu, Yuan Fang, et al.. (2020). The Effect of Long‐Term Traditional Chinese Medicine Treatment on Survival Time of Colorectal Cancer Based on propensity Score Matching: A Retrospective Cohort Study. Evidence-based Complementary and Alternative Medicine. 2020(1). 7023420–7023420. 19 indexed citations
14.
Que, Zujun, Yun Yang, Haitao Liu, et al.. (2020). Jinfukang regulates integrin/Src pathway and anoikis mediating circulating lung cancer cells migration. Journal of Ethnopharmacology. 267. 113473–113473. 27 indexed citations
15.
Que, Zujun, Bin Luo, Yi Jiang, et al.. (2020). Proteomics analysis of tumor exosomes reveals vital pathways of Jinfukang inhibiting circulating tumor cells metastasis in lung cancer. Journal of Ethnopharmacology. 256. 112802–112802. 12 indexed citations
16.
Que, Zujun, et al.. (2018). Jinfukang induced senescence of circulating tumor cells in lung cancer by p16/RB signal pathway. Tumori. 38(3). 215–221. 2 indexed citations
17.
Jin, Hui, Lifeng Liu, Weiping Deng, et al.. (2013). HDAC inhibitor DWP0016 suppresses miR-22 to induce growth inhibition and apoptosis via p53-independent PTEN activation in neuroblastoma SH-SY5Y cells. Process Biochemistry. 48(8). 1133–1142. 1 indexed citations
18.
Xu, Ling, Hegen Li, Lingshuang Liu, et al.. (2012). Multi-center randomized double-blind controlled clinical study of chemotherapy combined with or without traditional Chinese medicine on quality of life of postoperative non-small cell lung cancer patients. BMC Complementary and Alternative Medicine. 12(1). 112–112. 34 indexed citations
19.
Zheng, Yuanhong, Vanminh Le, Zhuoan Cheng, et al.. (2012). Development of rapid and highly sensitive HSPA1A promoter-driven luciferase reporter system for assessing oxidative stress associated with low-dose photodynamic therapy. Cell Stress and Chaperones. 18(2). 203–213. 21 indexed citations
20.
Tian, Jianhui. (2006). Correlative Factors for Cancer Response Evaluation Treated by TCM. Shanghai Journal of Traditional Chinese Medicine. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026